BioLife Solutions SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines

“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools and services for cell and gene therapies, announced its recently acquired SciSafe division has been awarded a two year contract from a large pharmaceutical company for cold chain management and storage of COVID-19 vaccines. The contract value is approximately $2.7 […]